NVCR Q2 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$150M+19.3% YoY

Gross Profit

$116M77.0% margin

Operating Income

-$34M-22.4% margin

Net Income

-$33M-22.2% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$13M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$850M

Stockholders' Equity

$362M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$150M	$126M	+19.3%
Gross Profit	$116M	$92M	+25.7%
Operating Income	-$34M	-$63M	+46.4%
Net Income	-$33M	-$57M	+41.9%

Geographic Segments

UNITED STATES

$96M51%

International Markets

$49M26%

GERMANY

$15M8%

FRANCE

$14M8%

JAPAN

$8M4%

CHINA

$6M3%